Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_843659aad9c4fcabeaa8bd2c0728a181 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10332 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10321 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-163 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K30-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K30-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
filingDate |
2017-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_857664b5df5ae01e535f6e0c7b027204 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f22753ef8cbfe9b7f29430258d9eb0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b7d5a6dc2f3bcfc0e8a8bdf1fedc10c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11e3ca902f57e7d5066747eaac80320e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef71749098f9abb241a683b977cbd92 |
publicationDate |
2019-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019321423-A1 |
titleOfInvention |
Escherichia coli bacteriophage esc-cop-9 and use for inhibiting proliferation of pathogenic escherichia coli thereof |
abstract |
The present invention relates to Myoviridae bacteriophage Esc-COP-9 (Accession No. KCTC 13131BP) isolated from nature, which has a genome represented by SEQ ID NO: 1 and an ability to specifically kill E.coli , and a method for preventing and treating pathogenic E. coli infections by using a composition comprising the same as an active ingredient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058131-B2 |
priorityDate |
2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |